Recently, the State Administration for Market Regulation issued the modified “Regulation Provision for imported medicinal materials,” which will be implemented on January 1, 2020. The “Provision” stipulates that more medicinal materials should be imported, and the imported medicinal materials should be classified and managed. The management of the imported medicinal material that is not done for the first time should be simplified according to the risk level, thereby reducing the time for examination and approval of imported medicinal materials. When purchasing imported drugs, the regulations of drug traceability should be strictly implemented.
《进口药材管理办法》发布，进口流程将简化
来源：制药网 2019.05.23
核心提示：日前，国家市场监督管理总局发布了修订后的《进口药材管理办法》（以下简称《办法》）并将于2020年1月1日起开始实施。《办法》要求，应鼓励更多药材进口，并对进口药材进行分类管理；根据风险级别简化非首次进口药材的进口管理，从而缩短进口药材的审批时间；在采购进口药品时，应严格执行药品追溯管理的有关规定。
Leave a Reply